BSE Live
Feb 04, 16:01Prev. Close
148.35
Open Price
150.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 04, 15:58Prev. Close
148.59
Open Price
150.00
Bid Price (Qty.)
170.27 (3144)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Suven Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -47.08 | -9.01 | -20.13 | -36.25 | -27.95 | |
| Net CashFlow From Operating Activities | -47.39 | -20.56 | -10.09 | -36.62 | -36.68 | |
| Net Cash Used In Investing Activities | 44.21 | -0.68 | -361.66 | -107.46 | 2.41 | |
| Net Cash Used From Financing Activities | -0.76 | -1.05 | 395.54 | 145.69 | 34.86 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -3.94 | -22.30 | 23.79 | 1.61 | 0.58 | |
| Cash And Cash Equivalents Begin of Year | 4.40 | 26.70 | 2.90 | 1.29 | 0.71 | |
| Cash And Cash Equivalents End Of Year | 0.46 | 4.40 | 26.70 | 2.90 | 1.29 |
30.01.2026
Suven Life Sci Consolidated December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
30.01.2026
Suven Life Sci Standalone December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
30.01.2026
Suven Life Sci Consolidated December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
30.01.2026
Suven Life Sci Standalone December 2025 Net Sales at Rs 2.81 crore, up 74.46% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y